Evidence map›Paper›PMID 30510775›Full record

ArticleNPJ vaccines2018

Pre-clinical evaluation of a

António M Mendes, Isaie J Reuling, Carolina M Andrade, Thomas D Otto, Marta Machado, Filipa Teixeira, Joana Pissarra, Nataniel Gonçalves-Rosa, Dolores Bonaparte, João Sinfrónio and 10 more

Open access · goldAbstract read
In one paragraph

Article in NPJ vaccines, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Generation of a Genetically Modified ChimericFrontiers in cellular and infection microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 5 countries.

António M Mendes1Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal.ORCID 0000-0001-6562-5325
Isaie J Reuling *2Department of Medical Microbiology, Radboud University Medical Center, Geert Grooteplein 28, Microbiology 268, 6500 HB Nijmegen, The Netherlands.ORCID 0000-0002-1783-0735
Carolina M Andrade *1Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal.ORCID 0000-0002-9763-8857
Thomas D Otto3Parasite Genomics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA UK.ORCID 0000-0002-1246-7404
Marta Machado1Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal.
Filipa Teixeira1Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal.
Joana Pissarra1Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal.
Nataniel Gonçalves-Rosa1Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal.ORCID 0000-0001-5571-8616
Dolores Bonaparte1Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal.
João Sinfrónio1Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal.
Mandy Sanders3Parasite Genomics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA UK.
Chris J Janse4Leiden Malaria Research Group, Parasitology, Center of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Shahid M Khan4Leiden Malaria Research Group, Parasitology, Center of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Chris I Newbold3Parasite Genomics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA UK.
Matthew Berriman3Parasite Genomics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA UK.
Cynthia K LeePATH's Malaria Vaccine Initiative, 455 Massachusetts Ave, Washington, DC 20001 USA.
Yimin WuPATH's Malaria Vaccine Initiative, 455 Massachusetts Ave, Washington, DC 20001 USA.
Christian F OckenhousePATH's Malaria Vaccine Initiative, 455 Massachusetts Ave, Washington, DC 20001 USA.
Robert W Sauerwein2Department of Medical Microbiology, Radboud University Medical Center, Geert Grooteplein 28, Microbiology 268, 6500 HB Nijmegen, The Netherlands.
Miguel Prudêncio1Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal.ORCID 0000-0003-1746-6029
University of Lisbon · PTWellcome Sanger Institute · GBU.S. President's Malaria Initiative · USLeiden University Medical Center · NLRadboud University Nijmegen · NL

Funding

Wellcome Trust
6 · The paper itself

Abstract

Whole-sporozoite vaccination/immunization induces high levels of protective immunity in both rodent models of malaria and in humans. Recently, we generated a transgenic line of the rodent malaria parasite

Identifiers

PMID30510775
PMCPMC6258718
OpenAlexW2900927973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.